Medicine
Clorazepate 3.75 mg tablet
Clorazepate 3.75 mg tablet is a generic prescription medicine for oral use, made by 5 labelers, with its source record on the US FDA register. It is available on request for export supply from India to licensed hospitals, importers and physicians.
Availability
Export supply from India to licensed buyers
Typical lead time
On request
Counted from payment and complete documents
Shipping
Ambient
Store at 20° to 25°C (68° to 77°F). Protect from light and moisture.
Key facts
- Active ingredient (INN)
- Clorazepate
- Brand
- Sold under the generic name
- Strength
- 3.75 mg
- Dosage form
- Tablet
- Route
- Oral
- Packs
- 100 tablets, 500 tablets, 1000 tablets and 11 more
- Manufacturers
- Aurolife PharmaIndiaSun Pharmaceutical IndustriesIndiaANI PharmaceuticalsNorthStar RxClinical Solutions Wholesale
- Origin register
- US FDA, United States
- Storage
- Store at 20° to 25°C (68° to 77°F). Protect from light and moisture.
- Cold chain
- Not required on record
- Prescription status
- Prescription only
- Controlled substance
- Schedule CIV
- ATC code
- N05BA05 Clorazepate
- HS code (indicative)
- 3004.90Indicative only. Your customs broker confirms the final tariff code.
- Marketing category
- marketed
- Marketed since
- 17 July 1987
- Identifiers
- RxCUI 197464, 197465, 197466DailyMed set ID 919cbd07-f587-4005-acff-26213dd1d1fb, fb5c9e98-02b2-4c36-b436-25b58fe3c7d5, a4b80e69-b7c7-471a-8ce8-4e992808c669 +3NDC 13107-319, 72603-112, 70954-159 +3Application ANDA071858, ANDA075731, ANDA213730
Record updated 12 November 2026
Documents available
Documents that can be provided with this medicine. Your regulator may ask for more, and the quote lists the full set.
No document list is recorded for this medicine yet. Tell us which documents your regulator needs (for example a CoA, COPP or GMP certificate) when you request a quote.
Packs
Packs from every labeler of this generic presentation.
| Pack | Code | Labeler | Marketed since |
|---|---|---|---|
| 100 tablet in 1 bottle | 13107-282-01 | Aurolife PharmaIndia | 23 September 2023 |
| 500 tablet in 1 bottle, plastic | 13107-282-05 | Aurolife PharmaIndia | 23 September 2023 |
| 100 tablet in 1 bottle | 13107-319-01 | Aurolife PharmaIndia | 17 July 1987 |
| 500 tablet in 1 bottle, plastic | 13107-319-05 | Aurolife PharmaIndia | 17 July 1987 |
| 100 tablet in 1 bottle | 51672-4042-1 | Sun Pharmaceutical IndustriesIndia | 27 April 2000 |
| 500 tablet in 1 bottle | 51672-4042-2 | Sun Pharmaceutical IndustriesIndia | 27 April 2000 |
| 1000 tablet in 1 bottle | 51672-4042-3 | Sun Pharmaceutical IndustriesIndia | 27 April 2000 |
| 100 tablet in 1 bottle | 70954-159-10 | ANI Pharmaceuticals | 16 June 2022 |
| 500 tablet in 1 bottle | 70954-159-20 | ANI Pharmaceuticals | 1 July 2022 |
| 30 tablet in 1 bottle | 70954-159-30 | ANI Pharmaceuticals | 21 August 2023 |
| 30 blister pack in 1 box, unit-dose / 1 tablet in 1 blister pack | 70954-159-50 | ANI Pharmaceuticals | 15 June 2025 |
| 30 tablet in 1 blister pack | 58118-4042-8 | Clinical Solutions Wholesale | 24 July 2026 |
| 100 tablet in 1 bottle | 72603-112-01 | Northstar RX | 24 October 2022 |
| 500 tablet in 1 bottle | 72603-112-02 | Northstar RX | 24 October 2022 |
Status by register
Where this medicine is registered, from the source record and the regulator data we hold. Ask us about a country that is not listed.
| Register | Status | Source |
|---|---|---|
| US FDA | Listed, marketed | Source record for this pageChecked 12 November 2026 |
| US FDA | First approved 23 June 1972 | Drugs@FDA |
| EU (EMA) | Not recorded | — |
| India (CDSCO) | Not yet confirmed against CDSCO approval lists | — |
| United States | Registered | US FDA (NDC directory, openFDA)Checked 12 November 2026 |
Import route
Pick the destination country to see the legal import route, who applies and typical timelines, from our import guide for that country.
Import guides are available for 25 countries. Pick one to see its route summary.
BrazilColombiaEgyptEthiopiaGhanaIraqKazakhstanKenyaAll import guides
Other strengths and forms of Clorazepate
Clinical summary
Clorazepate is a benzodiazepine indicated for the management of anxiety disorders or for the short-term relief of the symptoms of anxiety, among other approved uses. It is available as tablets for oral use. MedsAcross supplies Clorazepate for export from India to licensed hospitals, importers and physicians acting for named patients, with the documents each country requires.
Information from the US FDA prescribing information, retrieved 12 November 2026. Not yet medically reviewed.How we review
Read about ClorazepateFor healthcare professionals and buyers. This is not medical advice. Treatment decisions belong to the prescriber.
Data sources
- DailyMed label record · Checked 12 November 2026
- Clorazepate Dipotassium prescribing information (Apotex) · U.S. National Library of Medicine, DailyMed
Need Clorazepate 3.75 mg tablet for your hospital or patient?
Send one request with the destination country and quantity. We confirm availability, lead time and the documents your regulator needs.